DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Song Y, Huang Z, Liu X. et al.
Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE-/-) mice.
Nanomedicine (Lond) 2019;
15 (01) 13-24
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.